Parmalat S.p.A.:企業の戦略・SWOT・財務情報

◆英語タイトル:Parmalat S.p.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3819
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Parmalat S.p.A. – Strategy, SWOT and Corporate Finance Report
Summary

Parmalat S.p.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Parmalat S.P.A (Parmalat) is a manufacturer and distributor of food products and beverages. The company’s product portfolio comprises of ultra-high temperature milk, flavoured milk, condensed milk, milk powder, fruit juices, soy drinks, tea and yogurt. It also offers probiotics, desserts, cheese, ice cream, ingredients and butter. The company markets products under Parmalat, Santal, Zymil, Vaalia, Fibresse, and Omega3 brand names. It has business presence in Italy, Russia, Portugal, and Australia. Parmalat develops products through its six R&D centers located in Australia, Canada, Italy, South Africa, the US, Brazil, Colombia and Venezuela. Parmalat is headquartered in Collecchio, Parma, Italy.

Scope

- Detailed information on Parmalat S.p.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Parmalat S.p.A. in the form of a SWOT analysis
- An in-depth view of the business model of Parmalat S.p.A. including a breakdown and examination of key business segments
- Intelligence on Parmalat S.p.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Parmalat S.p.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Parmalat S.p.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Parmalat S.p.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Parmalat S.p.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Parmalat S.p.A.: Company Overview 8
Parmalat S.p.A.: Overview and Key Facts 8
Parmalat S.p.A.: Overview 8
Parmalat S.p.A.: Key Facts 8
Parmalat S.p.A.: Key Employees 10
Parmalat S.p.A.: Key Employee Biographies 12
Parmalat S.p.A.: Major Products and Services 14
Parmalat S.p.A.: Company History 16
Parmalat S.p.A.: Management Statement 20
Parmalat S.p.A.: Locations and Subsidiaries 23
Parmalat S.p.A.: Key Competitors 25
Parmalat S.p.A.: Company Analysis 26
Parmalat S.p.A.: Business Description 26
Parmalat S.p.A.: SWOT Analysis 27
Parmalat S.p.A.: SWOT Overview 27
Parmalat S.p.A.: Strengths 27
Parmalat S.p.A.: Weaknesses 28
Parmalat S.p.A.: Opportunities 28
Parmalat S.p.A.: Threats 29
Parmalat S.p.A.: Corporate Financial Deals Activity 30
Parmalat S.p.A.: Financial Deals Overview 30
Parmalat S.p.A.: Targets and Partners 31
Parmalat S.p.A.: Top Deals 2014 – 2018YTD* 32
Parmalat S.p.A.: Advisors 33
Parmalat S.p.A.: Top Financial Advisors 33
Parmalat S.p.A.: Mergers and Acquisitions 34
Parmalat S.p.A.: Private Equity and Ownership 35
Parmalat S.p.A.: Recent Developments 36
Parmalat S.p.A.: News and Events Summary 36
Parmalat S.p.A.: Business Reorganization 37
Parmalat S.p.A.: Corporate Governance 37
Parmalat S.p.A.: Financial Deals 38
Parmalat S.p.A.: Financial Performance 38
Parmalat S.p.A.: Research & Development 38
Appendix 40
Contact Us 40
Methodology 40
About MarketLine 41

List of Tables
Table 1: Parmalat S.p.A.: Key Facts
Table 2: Parmalat S.p.A.: Key Employees
Table 3: Parmalat S.p.A.: Locations and Subsidiaries
Table 4: Parmalat S.p.A.: Key Competitors
Table 5: Parmalat S.p.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Parmalat S.p.A.: M&A Average Deal Size - Value (US$m)
Table 7: Parmalat S.p.A.: Targets and Partners
Table 8: Parmalat S.p.A.: Top Deals 2014 - 2018YTD*
Table 9: Parmalat S.p.A.: Financial Advisor Ranking by Value (US$m)
Table 10: Parmalat S.p.A.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: Parmalat S.p.A.: M&A Activity by Geography (2014 - YTD*2018)
Table 12: Parmalat S.p.A.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 13: Parmalat S.p.A.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 14: Parmalat S.p.A.: News and Events Summary
Table 15: Parmalat S.p.A.: Business Reorganization
Table 16: Parmalat S.p.A.: Corporate Governance
Table 17: Parmalat S.p.A.: Financial Deals
Table 18: Parmalat S.p.A.: Financial Performance
Table 19: Parmalat S.p.A.: Research & Development

List of Figures
Figure 1: Parmalat S.p.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Parmalat S.p.A.: M&A Average Deal Size - Value (US$m)
Figure 3: Parmalat S.p.A.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Parmalat S.p.A.: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: Parmalat S.p.A.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 6: Parmalat S.p.A.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Parmalat S.p.A.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aaron’s Inc:戦略・SWOT・企業財務分析
    Aaron's Inc - Strategy, SWOT and Corporate Finance Report Summary Aaron's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • SPAGO Nanomedical AB:医療機器:M&Aディール及び事業提携情報
    Summary Spago Nanomedical AB (Spago Nanomedical), formerly Spago Imaging AB is a research and development company that develops nanomedical products for the diagnosis and treatment of cancer. The company offers spagopix, a magnetic resonance imaging contrast agent to improve the visualization of sof …
  • LEO Pharma AS-医療機器分野:企業M&A・提携分析
    Summary LEO Pharma A/S (LEO Pharma) is a research-based pharmaceutical company. It undertakes the discovery, development, manufacture and commercialization of pharmaceuticals in the therapeutic areas dermatology and thrombosis. The company focuses on the treatment of diseases such as psoriasis, ecze …
  • The Norinchukin Bank
    The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report Summary The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Modernizing Medicine Inc:医療機器:M&Aディール及び事業提携情報
    Summary Modernizing Medicine Inc (MMI) is a technology company that offers healthcare electronic health records (EHR) solutions. The company offers data management system and electronic medical record systems in the areas of gastroenterology, ophthalmology, orthopedics, otolaryngology, pain manageme …
  • Barrett Business Services Inc (BBSI):企業の財務・戦略的SWOT分析
    Summary Barrett Business Services Inc (BBSI) is a management consulting company that offers business management solutions. The company’s services include human capital management, preferred payroll, and staffing. Its payroll services handles deductions, liens, tax levies, tax payments, w-2s, and wag …
  • IXICO Plc (IXI):企業の財務・戦略的SWOT分析
    Summary IXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints and assessing the safety and efficacy of drugs. The company offers products such as Assessa and trial tracker. Assessa provides web-based platform to tra …
  • Select Energy Services Inc (WTTR):企業の財務・戦略的SWOT分析
    Select Energy Services Inc (WTTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Camden Property Trust:企業の戦略・SWOT・財務情報
    Camden Property Trust - Strategy, SWOT and Corporate Finance Report Summary Camden Property Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Standard Life plc:企業のM&A・事業提携・投資動向
    Standard Life plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Standard Life plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Globavir Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Globavir Biosciences Inc (Globavir) is a biotechnology company that develop combination of drug therapies and diagnostic tests in the therapeutic areas of infection and immune-oncology. The company develops Globavir’s Drug Discovery Platform (GDDP), which generates small molecule candidates …
  • Kenra Professional, LLC:企業の戦略・SWOT・財務情報
    Kenra Professional, LLC - Strategy, SWOT and Corporate Finance Report Summary Kenra Professional, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Kumagai Gumi Co Ltd (1861):企業の財務・戦略的SWOT分析
    Kumagai Gumi Co Ltd (1861) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • AES Gener SA (AESGENER):企業の財務・戦略的SWOT分析
    AES Gener SA (AESGENER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ramelius Resources Limited:企業の戦略・SWOT・財務情報
    Ramelius Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Ramelius Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Aratana Therapeutics Inc (PETX):製薬・医療:M&Aディール及び事業提携情報
    Summary Aratana Therapeutics Inc (Aratana) is a provider of pet care solutions. The company develops, commercializing and markets biopharmaceutical products for medical condition in cats and dogs. Its pipeline portfolio consists of small molecule pharmaceuticals and large molecule biologics that aim …
  • Dawnrays Pharmaceutical (Holdings) Ltd (2348):企業の財務・戦略的SWOT分析
    Summary Dawnrays Pharmaceutical (Holdings) Ltd (Dawnrays) is a manufacturer of cephalosporin antibiotics and specific medicines. The company provides products such as cefoperazone sodium and sulbactam sodium sterile, cefoperazone sodium sterile, ceftazidime sterile, cefixme, ceftriaxone sodium crude …
  • Union Electrica SA:企業の戦略的SWOT分析
    Union Electrica SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • KPC Pharmaceuticals Inc (600422)-製薬・医療分野:企業M&A・提携分析
    Summary KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and botanical drugs. It also offers drugs such as xue …
  • Adaptive Biotechnologies Corp:医療機器:M&Aディール及び事業提携情報
    Summary Adaptive Biotechnologies Corp (Adaptive) specializes in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. The company’s product portfolio comprises immunoSEQ and clonoSEQ. It provides immunosequencing platform to laboratories for conductin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆